MatTek Corporation : Quotes, Address, Contact
For more than 25 years, MatTek has been the world leader in reliable in vitro human tissue model innovation.
Source: news-medical.net
📰 Primary Human Cells News
Primary Human Cells News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Primary Human Cells. Real-time updates on events, politics, business and more.
Verve Therapeutics Reports New Preclinical Data Demonstrating Potent and Durable Editing of ANGPTL3 Gene with VERVE-201 in Wild-type and LDLR-deficient Non-Human Primates
VERVE-201 Preclinical Data Supports Advancement of Drug Candidate Toward Clinical Development for Homozygous Familial Hypercholesterolemia, with Initiation of Clinical Trial Anticipated in 2024 Data... | March 3, 2023
United States Jen Robinson Andrew Bellinger Exchange Commission Editing Medicine Targeting Clinical Development For Homozygous Familial Hypercholesterolemia
Source: marketscreener.com
Frontiers | The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a devastating necrotizing skin disease. Key to its pathogenesis is mycolactone, the exotoxin virulence factor that is both immunosuppressive and cytotoxic. The discovery that the essential Sec61 translocon is the major cellular target of mycolactone explains much of the disease pathology, including the immune blockade. Sec61 inhibition leads to a loss in production of nearly all cytokines from monocytes, macrophages, dendritic cells and T c...
United States Western Australia Le Bon Scandj Rheumatol Rheumatol Oxford M Ulcerans Mycolactone Cytotoxicity
Source: frontiersin.org